Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Levamisole: a double blind immunological study

D J Webster, R H Whitehead, G Richardson

    Anticancer Research
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impacts of a Clinical Quality Registry on Lung Cancer Quality Measures: A Retrospective Observational Study of the Victorian Lung Cancer Registry.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2025
    Same author

    Medical student engagement with surgery and research during the COVID-19 pandemic: Supporting the future workforce for post-pandemic surgical recovery.

    International journal of surgery (London, England)·2021
    Same author

    The impact of the COVID-19 pandemic on UK medical education. A nationwide student survey.

    Medical teacher·2021
    Same author

    Need for improved public health protection of young people wanting body piercing: evidence from a look-back exercise at a piercing and tattooing premises with poor hygiene practices, Wales (UK) 2015.

    Epidemiology and infection·2018
    Same author

    The cost-effectiveness of follow-up strategies after cancer treatment: a systematic literature review.

    British medical bulletin·2018
    Same author

    Impact of specialist rehabilitation services on hospital length of stay and associated costs.

    The European journal of health economics : HEPAC : health economics in prevention and care·2017
    Same journal

    Corrigendum.

    Anticancer research·2026
    Same journal

    Geographic Variation in Stage at Diagnosis of Skin Cancer in the United States: A National Cancer Database Analysis.

    Anticancer research·2026
    Same journal

    Anti-tumor Effects of Loureirin A Treatment in Colorectal Cancer Cells <i>via</i> Inhibition of AKT Phosphorylation.

    Anticancer research·2026
    Same journal

    Bayesian Analysis to Refine East Asian Subgroup Estimates in the CLEAR Trial (Lenvatinib Plus Pembrolizumab <i>vs</i>. Sunitinib) for Advanced Renal Cell Carcinoma.

    Anticancer research·2026
    Same journal

    Pulsed Electromagnetic Field Increases Doxorubicin-induced Mitotic Slippage in MDA-MB-231 Breast Cancer Cells.

    Anticancer research·2026
    Same journal

    Geographic Disparities in Socioeconomic Factors and Advanced-stage Presentation in Rectosigmoid Cancer: A National Cancer Database Analysis.

    Anticancer research·2026
    See all related articles

    Levamisole did not alter immunological status in advanced cancer patients over 6 months. Side effects were common, suggesting potential non-immunological mechanisms or the need for longer treatment durations.

    Area of Science:

    • Immunology
    • Oncology
    • Pharmacology

    Background:

    • Levamisole is an immunomodulatory drug.
    • Its efficacy in advanced cancer patients requires further investigation.

    Purpose of the Study:

    • To assess the immunological effects of a 4-week levamisole course in cancer patients.
    • To evaluate side effects and treatment adherence.

    Main Methods:

    • Randomized, double-blind study.
    • Assessed immunological status using DNCB response, Mantoux response, lymphocyte count, PHA stimulation, and serum immunoglobulin levels.
    • Monitored patients for 6 months.

    Main Results:

    • No significant changes in immunological status were observed.

    Related Experiment Videos

  • 38% of patients experienced side effects, with 17% discontinuing treatment.
  • Variability in placebo group skin tests questioned previous findings.

    • Conclusions:

    • Levamisole's potential benefits in advanced cancer may not be immunologically mediated via the studied parameters.
    • Non-immunological mechanisms or longer treatment durations might be necessary.
    • Further research is needed to clarify levamisole's role.